🎥 In a recent interview, Caner Saygin, MD of The University of Chicago discusses the impact of clonal hematopoiesis on the outcomes of patients with ALL.

Click here to watch:

👉 ow.ly/XCUY50QXFxY

#ALLsm #Leusm #Leukemia #ESHAL2024 ESH (Haematology) #HemOnc

Looking forward to kicking this off tomorrow!
ESH (Haematology) #ESHAL2024

Thank you The Leukemia & Lymphoma Society for doing this podcast on hairy cell leukemia. I enjoyed discussing HCL with you. UChicago Leukemia Program UChicagoCancerCenter

🚨Caner Saygin, MD and his dynamic team have just uncovered a critical link between myeloid gene mutations and the treatment response in older adults with ALL.🩸🔬🧬
UChicagoCancerCenter UChicago Leukemia Program University of Chicago Hematology/Oncology Caner Saygin, MD Wendy Stock
ow.ly/Y9Eu50Qv1K9

Our study, led by incoming University of Chicago Hem/Onc Fellows Hannah Johnston, MD highlights the critical role of UChicagoCancerCenter in alleviating socioeconomic disparities for ALL care in our Chicago and NW Indiana community.
ALL patients referred/treated at experienced centers have better outcomes.

🗣️ MEET THE FACULTY OF #ESHAL2024 !
Register & join these global experts on March 1-3, 2024 in Stockholm 🇸🇪
Proceed here ➡ bit.ly/3po4iqe
4th How to Diagnose & Treat ACUTE #LEUKAEMIAS
Chairs: Dombret Hervé, @Gossenkoppele, Christoph Röllig, Wendy Stock
#ESHCONFERENCES

Congratulations to Geoff Parriott @UChicagoImmuno on his first author publication from our lab in Leukemia Journal. Thanks to our collaborators Elizabeth Bartom, Caner Saygin, MD, and Wendy Stock UChicagoCancerCenter UChicago Committee on Cancer Biology. More to follow ow.ly/Tc2m50QmHEm

Check out this interesting study, collaborative work led by Geoffrey Parriott and Barbara Kee of UChicago Committee on Cancer Biology, showing the role of E2a in thymic competition to prevent T-lymphoblastic leukemogenesis.
Hot off the press Leukemia Journal.